Grants and Contributions

As part of the international consortium project “UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies”, this project's objective is to use Chromatin Bio's bioinformatics platform to design novel gene regulatory elements, improving gene expression in Mediphage therapeutic constructs for Stargardt disease, while reducing sequence complexity and increasing manufacturing yields. Once generated, these constructs will be complexed with Entos proprietary ocular nanocarrier for in vivo evaluation by NRC and Entos. The best performing candidates will then be manufactured as msDNA drug substances for further therapeutic development.

Equipment expansion, modernization and automation to increase production capacity, improve productivity and produce new steel and aluminum products for the mining, manufacturing and forestry sectors, while mitigating the pressures of tariffs.

Expansion of fabrication capabilities and development of new export markets to reduce tariff exposure and diversify revenues.

Canadian SKA Scientists pursue cutting-edge research which contributes to the advancement of our understanding of the universe through innovative instrumentation and technology and observational research. In addition, Canadian SKA Scientists support the Canadian astronomical community by developing, enhancing and maintaining the capacity to scientifically exploit SKA data.

Xeos Technologies’ Nemo X Data Relay provides rugged data relay capabilities along with two-way satellite communications for autonomous vehicles.

Isidore in the province of Alberta, using fibre technology.

A program to support access to capital for small and medium sized business, entrepreneurial services and network creation, stimulating innovation and capacity growth in the region.

The project will support the agri-food innovation ecosystem by promoting technology adoption, business incubation, and facilitating regional sector planning.

Providing materials science and engineering support to develop Ripple’s EpidelTM technology for further use in ophthalmology and other indications.

The goal of the project work with Sungreen H2 is focused on the operational integration (“handshake”) of Ayrton’s H-Cell system with SungreenH2’s electrolyser system. Ayrton’s e-LOHC system is designed to take in hydrogen direct from an electolyser into our H-Cell unit to be chemically bound to our LOHC carrier oil. When integrated with an electyolyser the hydrogen does not require drying or to be pressurized within the electrolyser. By optimizing this integration, we believe we can improve the electrical efficiency of the electrolyser by up to 20%.